Focadhesin interacts with SALL4 to regulate EGFR signaling and oncogenesis in non-small cell lung cancer
{{output}}
Owing to drug resistance to therapeutic targets, there is an urgent demand to find and validate new potent targets for non-small cell lung cancer (NSCLC). Although high SALL4 expression significantly promotes lung cancer growth, its oncogenic mechanism remains... ...
